miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts
Open Access
- 22 September 2020
- Vol. 9 (9), 2143
- https://doi.org/10.3390/cells9092143
Abstract
Tumor growth and invasion occurs through a dynamic interaction between cancer and stromal cells, which support an aggressive niche. MicroRNAs are thought to act as tumor messengers to “corrupt” stromal cells. We previously demonstrated that miR-9, a known metastamiR, is released by triple negative breast cancer (TNBC) cells to enhance the transition of normal fibroblasts (NFs) into cancer-associated fibroblast (CAF)-like cells. EGF containing fibulin extracellular matrix protein 1 (EFEMP1), which encodes for the ECM glycoprotein fibulin-3, emerged as a miR-9 putative target upon miRNA’s exogenous upmodulation in NFs. Here we explored the impact of EFEMP1 downmodulation on fibroblast’s acquisition of CAF-like features, and how this phenotype influences neoplastic cells to gain chemoresistance. Indeed, upon miR-9 overexpression in NFs, EFEMP1 resulted downmodulated, both at RNA and protein levels. The luciferase reporter assay showed that miR-9 directly targets EFEMP1 and its silencing recapitulates miR-9-induced pro-tumoral phenotype in fibroblasts. In particular, EFEMP1 siRNA-transfected (si-EFEMP1) fibroblasts have an increased ability to migrate and invade. Moreover, TNBC cells conditioned with the supernatant of NFs transfected with miR-9 or si-EFEMP1 became more resistant to cisplatin. Overall, our results demonstrate that miR-9/EFEMP1 axis is crucial for the conversion of NFs to CAF-like cells under TNBC signaling.Keywords
Funding Information
- Fondazione Guido Berlucchi (Berlucchi Career Foundation grant)
- Agenzia Italiana del Farmaco, Ministero della Salute (GR-2016-02361750)
- Fondazione Umberto Veronesi (Fondazione Umberto Veronesi Fellowship)
This publication has 48 references indexed in Scilit:
- Stroma in normal and cancer wound healingThe FEBS Journal, 2019
- Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistanceMolecular Cancer, 2019
- Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasisJournal of Biomedical Science, 2019
- Role of tumor microenvironment in triple-negative breast cancer and its prognostic significanceChinese Journal of Cancer Research, 2017
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signallingBritish Journal of Cancer, 2013
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Breast Fibroblasts Modulate Early Dissemination, Tumorigenesis, and Metastasis through Alteration of Extracellular Matrix CharacteristicsNeoplasia, 2013
- Loss of Transforming Growth Factor-β Signaling in Mammary Fibroblasts Enhances CCL2 Secretion to Promote Mammary Tumor Progression through Macrophage-Dependent and -Independent MechanismsNeoplasia, 2010
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer ModelPLOS ONE, 2009
- Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 SecretionCell, 2005